After adjusting for age, race, MACS site, testing batch, PNPLA3 genotype, VAT area, and HOMA-IR, HIV serostatus was associated with lower prevalence of NAFLD (OR, 0.46; 95% CI, 0.26–0.79), consistent with our prior analysis (Table 3) [5]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.